navigation
4. CDC category C diagnoses
4.1 HIV related syndromes
4.1.1 HIV wasting syndrome
4.1.2 HIV encephalopathy
4.2 Protozoal diseases and infections with pneumocystis jiroveci
4.2.1 PneumocystisĀ jiroveci pneumonia
4.2.2 Extrapulmonary pneumocystis disease
4.2.3 Cerebral toxoplasmosis
4.2.4 Disseminated toxoplasmosis
4.2.5 Cryptosporidiosis
4.2.6 Isosporiasis
4.3 Fungal diseases
4.3.1 Oesophageal candidiasis
4.3.2 Candidiasis of trachea, bronchi or lungs
4.3.3 Cryptococcal meningitis
4.3.4 Other disseminated cryptococcosis
4.3.5 Disseminated coccidioidomycosis
4.3.6 Disseminated histoplasmosis
4.4 Bacterial diseases
4.4.1 Pulmonary TB
4.4.2 Extrapulmonary TB
4.4.3 Disseminated MAC disease
4.4.4a M. kansasii disease
4.4.4b M. avium or kansasii disease (old code MAK)
4.4.5 M. genavense disease
4.4.6a Disseminated mycobacterial disease other or indeterminated
4.4.6b Other pulmonary mycobacterial diseases
4.4.7 Recurrent Salmonella septicemia
4.4.8 Recurrent bacterial pneumonia
4.5 Viral diseases
4.5.1 Chronic mucocutaneous HSV ulceration
4.5.2 Visceral HSV disease
4.5.3 CMV retinitis
4.5.4 Other CMV disease
4.5.5 Progressive multifocal leukencephalopathy
4.6 Neoplastic diseases
4.6.1 Kaposi sarcoma
4.6.2 Non-Hodgkin’s lymphoma
4.6.3 Primary cerebral lymphoma
4.6.4 Invasive cervical carcinoma
4.7 Indeterminate intracerebral lesions
4.1 HIV related syndromes
4.1.1 HIV wasting syndrome (database code WAS)
Presumptive diagnosisĀ by
- Documented profound involuntary weight loss >10% from baseline. Baseline weight is weight at first consultation. Weight loss is calculated by averaging two similar weights on consecutive occasions during follow-up and comparing this mean to baseline
PLUS either
- persistent diarrhea (at least three stools of reduced consistency per day for >30 days)
OR
- fever for >30 days without concurrent specific cause (such as cancer, TB, MAC, specific cause of enteritis).
date
first date on which 1), 2) OR 1) + 3) exist together.
Definitive diagnosisĀ not accepted
4.1.2 HIV encephalopathy (database code DEM)
Presumptive diagnosisĀ by clinical findings of disabling cognitive and/or motor dysfunction interfering with occupations or activities of daily living (not “depression” or psychosis)
ANDĀ no condition other than HIV infection to explain the findings. (CSF examination or autopsy evidence helpful)
ANDĀ must have had CT or MRI scan.
date
from time of scan.
Definitive diagnosisĀ not accepted
Ā
4.2 Protozoal diseases
4.2.1 PneumocystisĀ jiroveci pneumonia (database code PCP)
Definitive diagnosisĀ by cytology/microscopy or histology
Presumptive diagnosis
a) IF ON PCP PROPHYLAXIS: History of dyspnea on exertion, or non-productive cough (within 3 months),Ā ANDĀ typical appearance of diffuse bilateral pulmonale infiltrate,Ā ANDĀ no bronchoscopy done or negative bronchoscopy after having received at least one week of PCP treatment,Ā ANDĀ no evidence of bacterial pneumonia,Ā ANDĀ responds to PCP treatment.
b) IF NOT ON PCP PROPHYLAXIS FOR AT LEAST TWO WEEKS & CD4 COUNT LESS THAN 200: History of dyspnea on exertion, or non-productive cough (within 3 months),Ā ANDĀ CXR normal, atypical or typical for PCP,Ā ANDĀ no bronchoscopy done or negative bronchoscopy after having received at least one week of PCP treatment,Ā ANDĀ no evidence of bacterial pneumonia,Ā ANDĀ responds to PCP treatment.
date
from abnormal CXR (or start of treatment).
4.2.2 Extrapulmonary pneumocystis disease (database code EPD)*
Definitive diagnosisĀ by histology/microscopy.
(Presumptive diagnosisĀ not accepted)
* This diagnosis used in the SHCS does not correspond to any of the CDC definitions.
4.2.3 Cerebral toxoplasmosis (database code TOX)
Definitive diagnosisĀ by histology or cytology
date
from date of biopsy
Presumptive diagnosisĀ by recent onset of focal neurological abnormality consistent with intracranial disease, or reduced level of consciousness, or headache
ANDĀ CT or MRI scan evidence of at least one lesion having a mass effect or enhancing with contrast medium
ANDĀ Responded to toxo. treatment (evidence from repeat scan and/or clinical improvement).
date
from time of scan
4.2.4 Disseminated toxoplasmosis (database code TOD)*
Definitive diagnosisĀ by histology or microscopy (not culture). There should be a concurrent illness consistent with the diagnosis. Can include lung.
(Presumptive diagnosisĀ not accepted)
* This diagnosis used in the SHCS does not correspond to any of the CDC definitions.
4.2.5 Cryptosporidiosis (database code SPO)
Definitive diagnosisĀ by
By stool microscopy or histology,
AND
must have reliable history of persistent diarrhea for >1 month.
date
from when diarrhea has persisted >1 month AND stool specimen taken with positive result.
(Presumptive diagnosisĀ not accepted)
4.2.6 Isosporiasis (database code ISO)
Definitive diagnosisĀ by microscopy of stool,
ANDĀ must have a reliable history of persistent diarrhea for >1 month.
date
from when diarrhea has persisted >1 month
ANDĀ stool specimen taken with positive result
Ā
4.3 Fungal diseases
4.3.1 Oesophageal candidiasis (database code ESO)
Definitive diagnosisĀ by macroscopic inspection at endoscopy,
OR
histology of biopsy,
OR
cytology of specimen from the mucosal surface (NOT by culture, NOT by barium swallow alone)
Presumptive diagnosis
- Recent onset of retrosternal pain/discomfort on swallowing (not nausea),Ā AND
- Oral candidiasis diagnosed as pseudomembranous candida on inspection, or diagnosed by microscopy of specimen from mucosal surface (not culture), or patient noted “oral candida”, was familiar with the appearance (e.g., documented prior episodes) and patient started treatment before seeing a doctor,Ā ANDĀ must respond to antifungal treatment.
date
from when 1 + 2 together
(Presumptive diagnosisĀ not accepted for 4.3.2 – 4.3.5)
4.3.2 Candidiasis of trachea, bronchi or lungs (database code CAN)
Definitive diagnosisĀ byĀ macroscopic inspection at endoscopy,
OR
histology of biopsy or cytology of specimen from mucosal surface.Ā NotĀ by culture.
4.3.3 Cryptococcal meningitis (database code COM)
Definitive diagnosisĀ by microscopy, or detection of antigen, or culture from CSF
4.3.4 Other disseminated cryptococcosis, extrapulmonary (database code COC)
Definitive diagnosisĀ by histology of extrapulmonary tissue, microscopy, or detection of antigen, or culture (e.g., blood, not sputum),
ANDĀ must have concurrent illness consistent with the diagnosis.
4.3.5 Disseminated coccidioidomycosis (database code CCM)
Definitive diagnosisĀ by microscopy, culture, or detection of antigen.Ā NotĀ from lungs, cervical or hilar lymph nodes.
4.3.6 Disseminated histoplasmosis (database code HIS)
Definitive diagnosisĀ by microscopy, culture, or detection of antigen.Ā NotĀ from lungs, cervical or hilar lymph nodes.
Ā
4.4 Bacterial diseases
4.4.1 Pulmonary tuberculosis (database code TBC)
Definitive diagnosisĀ by culture (not PCR)
Presumptive diagnosisĀ by showing acid-fast bacilli in sputum that is not confirmed by culture or PCR,
ANDĀ must respond to specific treatment
OR
suggestive infitrate on CXR,
ANDĀ (ananmnestic exposure to TB, or positive PPD test),
ANDĀ response to specific treatment
date
from specimen and CXR, respectively
4.4.2 Extrapulmonary tuberculosis (database code TEX)
(If patient has concurrent pulmonary TB please code also TBC)
Definitive diagnosisĀ by culture (notĀ lung alone).
Presumptive diagnosisĀ by showing acid-fast bacilli in stool, blood, body fluid or tissue, or in histology of cervical or hilar lymph nodes, of a species not identified by culture,
ANDĀ There is a concurrent definitive diagnosis of pulmonary TB
OR
responds to standard TB treatment
date
from specimen
4.4.3 Disseminated mycobacterium avium intracellular complex disease (database code MAC)
Definitive diagnosisĀ by culture (not by PCR) other than sputum, stool or skin
ANDĀ must have concurrent illness consistent with the diagnosis, e.g., weight loss, fever, diarrhea or anemia
date
from specimen
4.4.4a Mycobacterium kansasii disease (database code KAN)
Definitive diagnosisĀ by culture (not by PCR) in sputum, urine or stool (at least two specimens), or in normally sterile body fluid or biopsy
ANDĀ must have concurrent illness consistent with the diagnosis, e.g., pulmonary infitration, weight loss.
date
from specimen
4.4.4b Mycobacterium avium or kansasii disease (old database summary code MAK)
If sufficient information is available, this code should be replaced by MAC or KAN.
4.4.5 Mycobacterium genavense disease (database code GEN)
Definitive diagnosisĀ by culture (not by PCR) in sputum, urine or stool (at least two specimens), or in normally sterile body fluid or biopsy
ANDĀ must have concurrent illness consistent with the diagnosis.
date
from specimen
4.4.6a Disseminated mycobacterial disease other or indeterminate (database code MYC)
Definitive diagnosisĀ by culture (not by PCR) other than sputum, stool or skin. Include species other than M. tuberculosis, M. avium complex, M. kansasii or M. genavense,
ANDĀ must have concurrent illness consistent with the diagnosis.
date
from specimen
Presumptive diagnosisĀ by showing acid-fast bacilli in stool, or normally sterile body fluid (not sputum alone), or biopsy (not skin or lungs) where species not identified by culture,
ANDĀ must have a concurrent illness consistent with the diagnosis, as above.
date
from specimen
4.4.6b Other pulmonary mycobacterial diseases* (database code MYP)
Definitive diagnosisĀ by culture (not by PCR). Include species other than M. tuberculosis, M. kansasii or M. genavense,
ANDĀ must have concurrent illness consistent with the diagnosis.
* This category of diseases used in the SHCS does not correspond to any of the CDC definitions.
4.4.7 Recurrent Salmonella septicemia (database code SAL)
Definitive diagnosisĀ by blood culture, with history of previously treated blood-culture-confirmed Salmonella septicemia.
4.4.8 Recurrent bacterial pneumonia (database code BPN)
Definitive diagnosisĀ by two episodes of bacterial pneumonia within the last twelve months.
date
use the time of onset of the second episode
relapse
Is considered as a relapse every following bacterial pneumonia
Ā
4.5 Viral diseases
4.5.1 Chronic mucocutaneous Herpes Simplex ulceration (database code HSV)
Definitive diagnosisĀ byculture, microscopy, or detection of antigen,
ANDĀ must have a reliable history of persistent ulceration for >1 month,Ā NOTĀ including recurrent ulceration.
Presumptive diagnosis
Must have a reliable history of persistent ulceration for >1 month,Ā NOTĀ including recurrent ulceration,
ANDĀ responds to standard treatment
4.5.2 Visceral herpes simplex disease (database code HSD)
Definitive diagnosisĀ by culture, microscopy or detection of antigen with associated visceral disease
OR
positive specific PCR from CSF or from acqueous humor with associated CNS or retinal disease. (Presumptive diagnosisĀ not accepted)
4.5.3 CMV retinitis (database code RET)
Definitive diagnosisĀ by typical appearance,
ANDĀ positive specific PCR from acqueous humor
ANDĀ responds to CMV treatment.
Presumptive diagnosisĀ by characteristic appearance on ophthalmoscopic examination. (Discrete patches of retinal whitening with distinct borders speeding in a centrifugal manner, frequently associated with retinal vasculitis, hemorrhage and necrosis. Resolution of active disease leaves retinal scarring and atrophy with retinal pigment epithelial mottling).
date
from when clinician was sure of diagnosis
4.5.4 Other CMV disease (database code CMV)
Definitive diagnosisĀ by histology or cytology. Not liver, spleen, or lymph nodes. A positive culture alone from any site (except CSF) without histologic or cytologic evidence isĀ notĀ sufficient.
(Presumptive diagnosisĀ not accepted)
4.5.5 Progressive multifocal leukencephalopathy (database code PML)
Definitive diagnosisĀ by histology (not PCR for JC virus)
Presumptive diagnosisĀ by recent onset of neurological abnormality consistent with intracranial disease,
ANDĀ CT or MRI evidence of lesion consistent with PML
ANDĀ lack of evidence for lymphoma, toxoplasmosis (response to treatment),
orĀ HIV encephalopathy. Evidence for JC virus not necessary.
Ā
4.6 Neoplastic diseases
4.6.1 Kaposi’s sarcoma (database code KSA)
Definitive diagnosisĀ by histology
Presumptive diagnosisĀ by characteristic gross appearance of erythematous or violaceous plaque-like lesion on skin or mucous membrane. A presumptive diagnosis should not be made by a clinician who has seen few cases of KSA.
date
from time clinician was sure of the diagnosis
4.6.2 Non-Hodgkin’s lymphoma (database code NHL)
Corresponds to the old diagnoses IML (immunoblastic lymphoma) and BUL (Burkitt lymphoma)
Definitive diagnosisĀ by histology
(Presumptive diagnosisĀ not accepted)
date
from date of biopsy or time of good evidence of the presence of a mass (by scan) which is later biopsied to show lymphoma.
4.6.3 Primary cerebral lymphoma (database code LOB)
Definitive diagnosisĀ by histology
Presumptive diagnosisĀ by recent onset of focal neurological abnormality consistent with intracranial disease, or reduced level of consciousness
ANDĀ CT or MRI scan evidence of a lesion or lesions having a mass effect,
ANDĀ no response to toxo. treatment,
ANDĀ no evidence for lymphoma outside the brain.
date
from time of scan
4.6.4 Invasive cervical carcinoma (database code ICC)
Definitive diagnosisĀ by histology. Not intraepithelial neoplasia (CIN) or carcinoma-in-situ
(Presumptive diagnosisĀ not accepted)
4.7 Indeterminate intracranial lesions* (database code ILE)
Presumptive diagnosisĀ by disease due to intracranial lesion(s) where the differential diagnosis is primary cerebral lymphoma, toxoplasmosis, PML or HIV encephalopathy (DEM) but evidence is not sufficient to satisfy the corresponding criteria. Must have abnormal CT or MRI scan.
(Definitive diagnosisĀ not accepted)
date
from time of scan
* This category of diseases used in the SHCS does not correspond to any of theĀ CDCĀ definitions.